Park Marcelo, Sangean Marcia C, Volpe Marcia de S, Feltrim Maria I Z, Nozawa Emilia, Leite Paulo F, Passos Amato Marcelo B, Lorenzi-Filho Geraldo
Division of Emergency Medicine), Heart Institute (InCor), Hospital das Clínicas, University of São Paulo, Brazil.
Crit Care Med. 2004 Dec;32(12):2407-15. doi: 10.1097/01.ccm.0000147770.20400.10.
To compare the effects of oxygen, continuous positive airway pressure (CPAP), and bilevel positive airway pressure (bilevel-PAP) on the rate of endotracheal intubation in patients with acute cardiogenic pulmonary edema.
Randomized, controlled trial.
Tertiary hospital emergency room.
We randomly assigned 80 patients with severe cardiogenic acute pulmonary edema into three treatment groups. Patients were followed for 60 days after the randomization.
Oxygen applied by face mask, CPAP, and bilevel-PAP.
The rate of endotracheal intubation as well as vital signs and blood gases was recorded during the first 24 hrs. Mortality was evaluated at 15 days, at 60 days, and at hospital discharge. Complications related to respiratory support were evaluated before hospital discharge. Treatment with CPAP or bilevel-PAP resulted in significant improvement in the PaO2/FiO2 ratio, subjective dyspnea score, and respiratory and heart rates compared with oxygen therapy. Endotracheal intubation was necessary in 11 of 26 patients (42%) in the oxygen group but only in two of 27 patients (7%) in each noninvasive ventilation group (p = .001). There was no increase in the incidence of acute myocardial infarction in the CPAP or bilevel-PAP groups. Mortality at 15 days was higher in the oxygen than in the CPAP or bilevel-PAP groups (p < .05). Mortality up to hospital discharge was not significantly different among groups (p = .061).
Compared with oxygen therapy, CPAP and bilevel-PAP resulted in similar vital signs and arterial blood gases and a lower rate of endotracheal intubation. No cardiac ischemic complications were associated with either of the noninvasive ventilation strategies.
比较氧气、持续气道正压通气(CPAP)和双水平气道正压通气(双水平 PAP)对急性心源性肺水肿患者气管插管率的影响。
随机对照试验。
三级医院急诊室。
我们将 80 例重度心源性急性肺水肿患者随机分为三个治疗组。随机分组后对患者进行 60 天的随访。
面罩吸氧、CPAP 和双水平 PAP。
记录前 24 小时内的气管插管率以及生命体征和血气情况。在第 15 天、第 60 天和出院时评估死亡率。在出院前评估与呼吸支持相关的并发症。与氧疗相比,CPAP 或双水平 PAP 治疗使氧合指数(PaO2/FiO2)、主观呼吸困难评分以及呼吸和心率有显著改善。氧疗组 26 例患者中有 11 例(42%)需要气管插管,而各无创通气组 27 例患者中仅 2 例(7%)需要气管插管(p = 0.001)。CPAP 或双水平 PAP 组急性心肌梗死的发生率没有增加。氧疗组第 15 天的死亡率高于 CPAP 或双水平 PAP 组(p < 0.05)。直至出院时各组死亡率无显著差异(p = 0.061)。
与氧疗相比,CPAP 和双水平 PAP 使生命体征和动脉血气情况相似,且气管插管率更低。两种无创通气策略均未出现心脏缺血性并发症。